The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of the combination of regorafenib with conventional chemotherapy in patients with newly diagnosed multi-metastatic Ewing sarcoma: The Rego-Inter-Ewing-1 study.
 
Pablo Berlanga
Consulting or Advisory Role - EUSA Pharma (Inst); Merck KGaA (Inst)
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; EUSA Pharma
 
Dan Chaltiel
No Relationships to Disclose
 
Cyril Lervat
No Relationships to Disclose
 
Nadege Corradini
No Relationships to Disclose
 
Valerie Laurence
No Relationships to Disclose
 
Stephane Ducassou
No Relationships to Disclose
 
Lianne Havemann
No Relationships to Disclose
 
Marianne Phillips
No Relationships to Disclose
 
Jean Luc Joannic
No Relationships to Disclose
 
Line Claude
No Relationships to Disclose
 
Sandra Strauss
Consulting or Advisory Role - Boehringer Ingelheim; Ceridwen Oncology; GlaxoSmithKline; InhibRx; Tessallate Bio
Speakers' Bureau - Boehringer Ingelheim
Travel, Accommodations, Expenses - Adaptimmune
 
Roberto Luksch
Consulting or Advisory Role - Recordati; SERB Pharmaceuticals
Travel, Accommodations, Expenses - Recoati Rare Diseases
 
Hans Merks
Consulting or Advisory Role - Bayer; Merck KGaA
 
Karsten Nysom
Consulting or Advisory Role - Lilly
 
Camille Tron
No Relationships to Disclose
 
Tiphaine Adam de Beaumais
No Relationships to Disclose
 
Claudia Valverde Morales
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Deciphera; PharmaMar; Philogen
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Salim Laghouati
No Relationships to Disclose
 
Bernadette Brennan
No Relationships to Disclose
 
Nathalie Gaspar
Consulting or Advisory Role - EISAI; IPSEN
Travel, Accommodations, Expenses - Eisai; EISAI